Treatment of Mucocutaneous Disorders through Reversing Chronic Inflammation and Barrier Disruption.
Filed with US Patent Office- 2002 -2006; Continuation in Progress.
Method and Compositions for Disrupting Epithelial Barrier Function.
U.S. Patent 6,190,894 – Granted 02/20/2001
Pyridine-thiols reverse mucocutaneous aging.
U.S. Patent 6,071,593 – Granted 06/06/2000
Topical active agents to enhance the penetration of excipients.
U.S. Patent 5,760,096 – Granted 06/02/1998
Lipids for epidermal moisturization and repair of barrier function.
U.S. Patent 5,643,899 – Granted 01/01/1997
Use of dicarboxylic acids / analogs as penetration enhancers and toxicity blunting agents.
U.S. Patent 5,326,790 – Granted 07/05/1994
Treatment of a) skin disorders, b) skin tumors induced by viruses, and c) hyperpigmentation disorders all with monocarboxylic lipids. 
U.S. Patent 5,231,087 – Granted 07/27/1993
Treatment of viral tumors and hemorrhoids with sesquiterpenes.
U.S. Patent 5,219,880 – Granted 06/13/1993
Treatment of pruritus with monocarboxylic lipids.
U.S. Patent 5,057,500 – Granted 10/15/1991
Treatment of papulosquamous and eczematous diseases with combinations of carboxylic lipids and sesquiterpenes.
U.S. Patent 5,057,501 – Granted 10/15/1991
Treatment of psoriasis with sesquiterpenes.
U.S. Patent 4,978,676 – Granted 12/18/1990
Treatment of hyperhidrosis, ichthyosis and wrinkling with mono-and dicarboxylic lipids.
U.S. Patent 4,885,282 – Granted 12/05/1989
Treatment of inflammatory and / or hyperproliferative skin diseases in which pathogenic microbes play a significant role with amines of carboxylic lipids.
U.S. Patent 4,868,219 – Granted 08/19/1989
Treatment of non-acne inflammatory dermatoses, infectious cutaneous disease, and hair loss with dicarboxylic lipids.
U.S. Patent 4,713,394 – Granted 12/15/1987